Medications for Severe Acute Respiratory Syndrome (SARS)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Severe Acute Respiratory Syndrome (SARS).
Found 2 Approved Drugs for Severe Acute Respiratory Syndrome (SARS)
Veklury
Generic Name
Remdesivir
Veklury
Generic Name
Remdesivir
Form: Injection
Method of administration: Intravenous
FDA approval date: November 01, 2020
Classification: SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor
VEKLURY is indicated for the treatment of coronavirus disease 2019 (COVID-19) in adults and pediatric patients (28 days of age and older and weighing at least 3 kg) who are : Hospitalized, or Not hospitalized and have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death. VEKLURY is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleotide analog RNA polymerase inhibitor indicated for the treatment of coronavirus disease 2019 (COVID-19) in adults and pediatric patients (28 days of age and older and weighing at least 3 kg) who are: Hospitalized, or Not hospitalized and have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death. ( 1 )
Ritonavir
Brand Names
Lopinavir, Norvir, Paxlovid, Kaletra, Lopinavir-Ritonavir
Ritonavir
Brand Names
Lopinavir, Norvir, Paxlovid, Kaletra, Lopinavir-Ritonavir
Form: Tablet, Kit, Powder, Solution
Method of administration: Oral
FDA approval date: June 18, 2010
Classification: Protease Inhibitor
Ritonavir tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. Ritonavir tablets are HIV protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 ).
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances